ENTERO HEALTHCARE SOLUTIONS LIMITED Financials Entero Healthcare Solutions Limited
Equities
ENTERO
INE010601016
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,024 INR | -1.97% |
|
-0.38% | 0.00% |
| 05-29 | Entero Healthcare Solutions Limited Approves Director Changes | CI |
| 05-29 | Entero Healthcare Solutions Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: March | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 45,447 | - | - |
| Enterprise Value (EV) 1 | 37,396 | 42,077 | 45,441 |
| P/E ratio | 91.3 x | 37.8 x | 21.1 x |
| Yield | - | - | - |
| Capitalization / Revenue | 1.09 x | 0.83 x | 0.59 x |
| EV / Revenue | 0.95 x | 0.77 x | 0.59 x |
| EV / EBITDA | 33.4 x | 21 x | 13.4 x |
| EV / FCF | -44.6 x | -22.8 x | -18.3 x |
| FCF Yield | -2.24% | -4.39% | -5.47% |
| Price to Book | 2.62 x | 2.6 x | 2.32 x |
| Nbr of stocks (in thousands) | 43,494 | - | - |
| Reference price 2 | 1,045 | 1,045 | 1,045 |
| Announcement Date | 29/05/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | 39,223 | 54,757 | 77,558 |
| EBITDA 1 | - | 1,118 | 2,003 | 3,390 |
| EBIT 1 | - | 868.3 | 1,543 | 2,545 |
| Operating Margin | - | 2.21% | 2.82% | 3.28% |
| Earnings before Tax (EBT) 1 | - | 355.6 | 1,567 | 2,878 |
| Net income 1 | -115.6 | 391.1 | 1,203 | 2,152 |
| Net margin | - | 1% | 2.2% | 2.77% |
| EPS 2 | -0.1800 | 10.81 | 27.65 | 49.50 |
| Free Cash Flow 1 | - | -838.4 | -1,846 | -2,488 |
| FCF margin | - | -2.14% | -3.37% | -3.21% |
| FCF Conversion (EBITDA) | - | 6.45% | - | - |
| FCF Conversion (Net income) | - | 37.31% | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 03/08/23 | 29/05/24 | - | - |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | - | 5,552 | 3,370 | 6 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow 1 | - | -838 | -1,846 | -2,488 |
| ROE (net income / shareholders' equity) | - | 3.5% | 7% | 11.4% |
| ROA (Net income/ Total Assets) | - | 2.14% | 4.5% | 9.4% |
| Assets 1 | - | 18,268 | 26,726 | 22,894 |
| Book Value Per Share 2 | - | 377.0 | 401.0 | 451.0 |
| Cash Flow per Share | - | - | - | - |
| Capex 1 | - | 418 | 2,541 | 2,652 |
| Capex / Sales | - | 1.07% | 4.64% | 3.42% |
| Announcement Date | 03/08/23 | 29/05/24 | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1,045
INR
Average target price
1,509
INR
Spread / Average Target
+44.45%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 544M | |
| -3.91% | 29.9B | |
| +33.63% | 8.68B | |
| +39.80% | 4.56B | |
| -28.19% | 2.72B | |
| -8.96% | 1.61B | |
| -22.22% | 1.34B | |
| -37.12% | 1.08B | |
| +3.82% | 929M | |
| -43.36% | 791M |
- Stock Market
- Equities
- ENTERO Stock
- Financials Entero Healthcare Solutions Limited
